SERAP SUZUK YILDIZ

Dr. SERAP SUZUK YILDIZ


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2018 in Journal of Photochemistry and Photobiology B: Biology
Verified
Journal Article
Closed access
SMSireesh Babu Maddinedi
Sireesh Babu Maddinedi
JSJegatheeswaran Sonamuthu
Jegatheeswaran Sonamuthu
SYSERAP SUZUK YILDIZ
SERAP SUZUK YILDIZ
GHGuobin Han
Guobin Han
YCYurong Cai
Yurong Cai
JYJuming Yao
Juming Yao

1 March 2016 in Industrial Crops and Products
Verified
Journal Article
Closed access
Banu KaskatepeBanu Kaskatepe
Banu Kaskatepe
MKMerve Eylul Kiymaci
Merve Eylul Kiymaci
SYSERAP SUZUK YILDIZ
SERAP SUZUK YILDIZ
SESinem Aslan Erdem
Sinem Aslan Erdem
SCSalih Cesur
Salih Cesur
SYSulhiye Yildiz
Sulhiye Yildiz

27 January 2021 in Mikrobiyoloji Bulteni
Verified
Journal Article
Closed access
SYSERAP SUZUK YILDIZ
SERAP SUZUK YILDIZ
HŞHüsniye Şimşek
Hüsniye Şimşek
ZBZekiye Bakkaloglu
Zekiye Bakkaloglu
YCYasemin Numanoglu Cevik
Yasemin Numanoglu Cevik
CHCan Hüseyin Hekimoğlu
Can Hüseyin Hekimoğlu
Emine ALP MEŞEEmine ALP MEŞE
Emine ALP MEŞE
Antibiotic resistance is one of the most important public health problem and one of the most critical steps in preventing resistance is the monitorization of the resistance. Local, regional and global monitoring enables the spread of antibiotic resistance to be understood more clearly. In this study, it was aimed to evaluate the results of the pilot study for the establishment of molecular-based carbapenem surveillance system in Escherichia coli and Klebsiella pneumoniae isolates and to investigate the carbapenemase epidemiology in Turkey. Hospitals (n= 28) from 26 different statistical level II regions from Turkey were included in the study. The hospitals participated in the study submitted ten carbapenem susceptible and ten carbapenem resistant E.coli and K.pneumoniae isolates to our laboratory that were isolated in two different periiods of six-month either between 1 March-31 August or 1 April-30 September 2019. A total of 509 isolates were collected from 26 of the 28 participating hospitals in the study. Isolates were identified by matrix assisted laser desorptionization-time of flight mass spectrophotometry (MALDI TOF MS) (Bruker Daltonics, Germany) method and antibiotic susceptibility tests for imipenem, meropenem and colistin were studied by broth microdilution. Moreover, susceptibilities to amikacin, amoxicillin-clavulanic acid, ampicillin, aztreonam, cefepime, cefotaxime, ceftazidime, ciprofloxacin, ertapenem, gentamicin, piperacillin-tazobactam, tobramycin and trimethoprim-sulfamethoxazole were determined by disc diffusion method. The resistance genes were investigated in isolates which were found to be phenotypically resistant to carbapenem and colistin, in house method was used to investigate carbapenemase genes and a commercial colistin resistant real-time PCR kit (Biospeedy, Turkey) was used for colistin resistance genes. In total, 493 of the 509 isolates collected from hospitals were identified as E.coli (25.7%, n= 127) and K.pneumoniae (74.3%, n= 366) and included in the study. It was determined that 31% of the isolates evaluated were from community-acquired infections and 69% were either from healthcare-associated infections or from colonization sites. Among the tested isolates, 248 (50.3%) were susceptible to carbapenems and 245 (49.7%) were resistant. The types of carbapenemases in carbapenemase-producing isolates were OXA-48 (52.2%), KPC (16.1%), NDM-1 (15%), OXA-48 + NDM-1 (12.6%), KPC + NDM-1 (2.8%) and VIM (0.5%) and OXA-48+VIM (0.5%). Resistance to colistin was detected in 23.3% of the isolates but mcr1-8 genes were not detected. It was found that all colistin resistant isolates are resistant to at least one of the carbapenems. The importance of a molecular-based antimicrobial resistance surveillance system in our country was demonstrated with this pilot study. It is thought that continuous monitoring of these epidemiological features will contribute to the management of infections due to carbapenemase-producing organisms.

7 November 2018 in Acta Microbiologica Et Immunologica Hungarica
Verified
Journal Article
Closed access
SYSERAP SUZUK YILDIZ
SERAP SUZUK YILDIZ
Banu KaskatepeBanu Kaskatepe
Banu Kaskatepe
HŞHüsniye Şimşek
Hüsniye Şimşek
FSFatma Mutlu Sarıgüzel
Fatma Mutlu Sarıgüzel
When the problem with carbapenem-resistant Enterobacteriaceae (CRE) increases, the older antimicrobial agents such as colistin and fosfomycin are used for the treatment of these infections. In this study, the broth microdilution method for colistin and the agar dilution method for fosfomycin were used for a total of 147 multidrug-resistant (MDR) or extensively drug-resistant (XDR) strains of CRE. The study included Klebsiella pneumoniae (91.16%), Escherichia coli (7.48%), Enterobacter cloacae (0.68%), and Serratia marcescens (0.68%). All these strains produce various types of carbapenemase, including OXA-48, NDM, and KPC. Some of these strains also have three different carbapenemase mechanisms, including OXA-48 (78.23%), NDM (2.04%), and KPC (0.68%) or OXA-48 and NDM (10.88%), or OXA-48 and KPC (0.68%). About 76.19% of the strains and 67.35% of the strains were resistant for colistin and fosfomycin, respectively. A total of 21 out of 35 colistin-susceptible strains were found to be susceptible to fosfomycin. This study showed that the resistance rates of colistin and fosfomycin are high. The MDR and XDR strains of CRE are spreading in our region and thus a monitoring system for CRE should be followed. Moreover, the applicability of antimicrobial stewardship programs should be increased in all inpatient and outpatient settings.

1 December 2017 in Acta Biologica Hungarica
Verified
Journal Article
Closed access
Banu KaskatepeBanu Kaskatepe
Banu Kaskatepe
SYSERAP SUZUK YILDIZ
SERAP SUZUK YILDIZ
MKMerve Eylul Kiymaci
Merve Eylul Kiymaci
AYAyse Nur Yazgan
Ayse Nur Yazgan
SCSalih Cesur
Salih Cesur
SESinem Aslan Erdem
Sinem Aslan Erdem
In recent years rapidly growing antibiotic resistance has increased interest toward natural products, especially essential oils because of their various effects. The aim of this study was to identify the chemical composition of the commercial Origanum onites essential oil (EO) and to investigate the antimicrobial activity by disc diffusion and dilution methods, against ten different ATCC strains, including eight bacteria, two yeasts and seventy-nine clinical nosocomial Escherichia coli isolates that produce extended spectrum beta lactamase (ESBL). The chemical composition of EO was analyzed by GC and GC-MS. The major compounds of the EO were determined as carvacrol (51.4%) followed by linalool (11.2%), p-cymene (8.9%) and γ-terpinene (6.7%). O. onites EO had antimicrobial activity against all standard strains and inhibited microbial growth of ESBL positive E. coli isolates. According to our results, O. onites EO may be an alternative to synthetic drug, used in combination with other antibiotics for treatm...

14 December 2023 in American Journal of Infection Control
Verified
Journal Article
Closed access
EEEsma Eryilmaz-Eren
Esma Eryilmaz-Eren
SYSuleyman Yalcin
Suleyman Yalcin
FOFirat Ozan
Firat Ozan
ESEsma Saatci
Esma Saatci
SYSERAP SUZUK YILDIZ
SERAP SUZUK YILDIZ
IÇIlhami Çelik
Ilhami Çelik